RxDoctor Payments Data
★ My doctorsLook up a doctor →

Athena Vanzant

Endocrinology, Diabetes & Metabolism · South Miami, FLNPI 1366568008

Payments from drug & device makers

$18,801in general payments, 2019–2025

Across 845 payments — averaging $22.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • Lilly USA, LLC$2K
  • AstraZeneca$1K
  • Boehringer Ingelheim$1K
  • Mannkind Corporation$928
  • Insulet Corporation$873
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$18,777100%
  • Education$240%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk136$3,195
Lilly USA, LLC106$2,161
AstraZeneca(2 entities)37$1,066
Boehringer Ingelheim38$1,006
Mannkind Corporation46$928
Insulet Corporation31$873
Abbott39$824
Sanofi-aventis U.S. LLC34$798
Amgen(2 entities)41$747
Xeris Pharmaceuticals, Inc.32$662
AbbVie39$644
Tandem Diabetes Care, Inc.23$524
Bayer20$459
Dexcom, Inc.16$419
Recordati_rare_diseases_inc.16$417
Radius Health, Inc.18$357
Antares Pharma, Inc.12$259
Amneal Pharmaceuticals LLC15$250
Corcept Therapeutics12$240
Medtronic10$199
Sequel Med Tech, LLC10$198
Embecta Corp.10$192
Alvogen Inc7$165
IBSA Pharma Inc.9$164
Cequr Corporation3$160
Pfizer6$142
Neurocrine Biosciences, Inc.1$137
Amarin Pharma, Inc.7$133
Kyowa Kirin, Inc.5$119
Zealand Pharma US, Inc.6$116
Ascendis Pharma Endocrinology Inc5$110
Verity Pharmaceuticals Inc.3$109
Currax Pharmaceuticals LLC6$88
Halozyme Inc4$87
Acella Pharmaceuticals, LLC3$67
Azurity Pharmaceuticals, Inc.3$66
Amphastar Pharmaceuticals, Inc.3$60
Alfasigma USA, Inc.3$56
Merck2$44
Clarus Therapeutics Inc.2$41
Roche Diabetes Care, Inc.2$41
BD2$40
Amryt Pharma Holdings Ltd2$40
Vivus LLC2$38
Ascensia Diabetes Care US Inc.2$37
Tolmar, Inc.2$35
Ionis Pharmaceuticals, Inc.1$34
GSK1$23
Sanofi Pasteur Inc.1$23
Madrigal Pharmaceuticals1$22
Rhythm Pharmaceuticals, Inc.1$22
Chiesi USA, Inc.1$22
Ipsen Biopharmaceuticals, Inc1$21
Aimmune Therapeutics, Inc.1$20
Evoke Pharma, Inc.1$19
Gilead1$19
Ultragenyx Pharmaceutical Inc.1$18
Intuity Medical Inc1$16
Vistapharm, Inc.1$14
Acerus Pharmaceuticals Corporation1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,801 in reported general payments places this provider in the 75th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide370$517,854
MounjaroTirzepatide371$422,447
JardianceEmpagliflozin117$160,092
FarxigaDapagliflozin Propanediol81$102,285
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/737$50,782
Tresiba Flextouch U-100Insulin Degludec50$37,976
TrulicityDulaglutide32$36,915
Tresiba Flextouch U-200Insulin Degludec26$31,965
Humalog Kwikpen U-200Insulin Lispro12$30,798
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog23$30,131
RybelsusSemaglutide22$27,267
TradjentaLinagliptin18$18,888
Fiasp FlextouchInsulin Aspart (Niacinamide)15$17,624
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog23$14,110
Novolog FlexpenInsulin Aspart33$11,979

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$3,195$545,121392 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog$2,161$467,459422 claims
Boehringer IngelheimJardiance, Tradjenta$1,006$178,980135 claims
AstraZenecaFarxiga$1,066$102,28581 claims
AbbVieSynthroid$644$9,92389 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$250$2,351188 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

Other endocrinology, diabetes & metabolism in South Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →